Welcome to the e-CCO Library!

P442: Real-world endoscopic and histologic outcomes are linked to ustekinumab exposure in Ulcerative Colitis
Year: 2022
Source: ECCO'22
Authors: Alsoud, D.(1);Compernolle, G.(2);Tops, S.(2);Sabino, J.(1,3);Ferrante, M.(1,3);Thomas, D.(2);De Hertogh, G.(4);Vermeire, S.(1,3);Verstockt , B.(1,3);
Created: Friday, 11 February 2022, 3:52 PM
P442: Serum vedolizumab trough levels are associated with remission rate but not with extra-intestinal manifestations in IBD patients
Year: 2021
Source: ECCO'21 Virtual
Authors: Tzadok, R.(1);Fliss-Isakov, N.(2);Aviv Cohen, N.(2);Ron, Y.(2);Maharshak, N.(2);Hirsch, A.(2);
Created: Wednesday, 2 June 2021, 4:12 PM
P442: Strictureplasty for Crohn’s disease of the small bowel in the biological era: long-term outcomes and risk factors for site specific recurrence
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

M. Rottoli*1, C. A. Manzo1, M. Tanzanu1, F. Rizzello1, P. Gionchetti1, G. Poggioli1

Created: Friday, 22 February 2019, 9:41 AM
P442: The additional value of cytapheresis therapy in patients with severe ulcerative colitis treated with oral tacrolimus
Year: 2018
Source: ECCO '18 Vienna
Authors:

S. Takahashi*, M. Colvin, J. Toyosawa, M. Ishida, T. Kagawa, S. Kuraoka, Y. Aoyama, K. Okamoto, I. Sakakihara, K. Izumikawa, K. Yamamoto, S. Tanaka, M. Matsuura, S. Ishikawa, M. Wato, T. Hasui, T. Inaba

Created: Thursday, 21 February 2019, 9:14 AM
P443 Magnetic resonance imaging after ligation of the intersphincteric fistula tract for high perianal fistulas in Crohn’s disease: a retrospective cohort study
Year: 2020
Source:

ECCO'20 Vienna

Authors:

E. Van Praag1, K. van Rijn2, M. Monraats2, J. Stoker2, C. Buskens1

Created: Thursday, 30 January 2020, 10:12 AM
P443: Clinical features, therapeutic requirements, and evolution of patients with Crohn's disease and upper digestive tract involvement (CROHNEX study)
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

E. Sainz Arnau*1, Y. Zabana2, I. Miguel3, A. Fernández Clotet4, M. J. Casanova5, M. D. Martín6, M. D. Picó7, E. Alfambra8, I. Rodriguez9, F. Muñoz10, M. Domínguez11, E. Iglesias12, D. Busquets13, A. Gutiérrez14, F. Cañete15, L. Nuñez16, C. Taxonera17, B. Beltrán18, B. Camps19, X. Calvet20, P. Navarro21, M. Calafat22, R. Ferreiro-Iglesias23, C. González-Muñoza24, B. Sicilia25, C. Rodríguez26, A. Y. Carbajo27, M. van Domselaar28, R. Vicente29, M. Piqueras30, M. C. Muñoz31, À. Abad32, A. Algaba33, P. Martínez34, M. I. Vela35, B. Antolín36, J. M. Huguet37, L. Bujanda38, R. H. Lorente39, P. Almela40, M. J. García41, P. Ramírez de la Piscina42, R. Pajares43, I. Pérez-Martínez44, A. J. Lucendo45, O. Merino46, J. Legido47, I. Vera48, V. J. Morales49, M. Esteve2

Created: Friday, 22 February 2019, 9:41 AM
P443: Haemorrhoidal Artery Ligation – Recto-Anal Repair (HAL-RAR) with mucopexy for grade III hemorrhoids in IBD patients
Year: 2021
Source: ECCO'21 Virtual
Authors: Laureti, S.(1);Cardelli, S.(1);Gionchetti, P.(1);Rizzello, F.(1);Calabrese, C.(1);Poggioli, G.(1);
Created: Wednesday, 2 June 2021, 4:12 PM
P443: National treatment strategy in inflammatory bowel diseases in Hungary: results from the National Health Insurance Fund Prescription Database
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

Z. Kurti*1, L. Gonczi1, P. A. Golovics1, B. Lovasz1, P. Fadgyas-Freyler2, J. Gimesi-Orszagh2, G. B. Korponai2, Z. Vegh1, P. Lakatos1

Created: Friday, 22 February 2019, 9:49 AM
P443: Risk of incident Cancer in Patients with Inflammatory Bowel Disease with Prior Breast Cancer: a Multicentre Cohort Study
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Le Cosquer, G.(1);Gilletta, C.(1);Amiot, A.(2);Rivière, P.(3);Nachury, M.(4);Rouillon, C.(5);Bouhnik, Y.(6);Abitbol, V.(7);Nancey, S.(8);Fumery, M.(9);Savoye, G.(10);Biron , A.(11);Picon, L.(12);Peyrin-Biroulet, L.(13);Vidon, M.(14);Reenaers, C.(15);Simon, M.(16);Caron, B.(13);Serrero , M.(17);Altwegg, R.(18);Benezech, A.(19);Goutorbe, F.(20);Rahier, J.F.(21);Beaugerie, L.(22);Pelletier, A.L.(23);Caillo, L.(24);Laharie, D.(3)*;Poullenot, F.(3);
Created: Friday, 14 July 2023, 11:05 AM
P443: Systematic analysis of annual health resource utilisation and costs in hospitalised inflammatory bowel disease patients in Switzerland
Year: 2018
Source: ECCO '18 Vienna
Authors:

A. Schoepfer1*, S. Vavricka2, B. Bruengger3, O. Reich3, E. Blozik3, C. Bähler3

Created: Thursday, 21 February 2019, 9:14 AM
P443: Systematic review of internet decision making resources for patients considering surgery for ulcerative colitis
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Baker D.*1, Marshall J.1, Lee M.2, Jones G.3, Brown S.2, Lobo A.4

Created: Wednesday, 20 February 2019, 10:36 AM
P443: Trough concentration response in infliximab and adalimumab treated children with IBD following treatment adjustment: A pharmacokinetic model.
Year: 2022
Source: ECCO'22
Authors: Levi, R.(1);Matar, M.(1);Zvoluni, M.(1);Shamir, R.(1);Assa, A.(1);
Created: Friday, 11 February 2022, 3:52 PM
P444 The impact of azathioprine on inflammatory bowel disease patients’ overall health-related quality of life: a single-centre retrospective cohort study
Year: 2020
Source:

ECCO'20 Vienna

Authors:

Y. ALRUTHIA1, W. Alsharif1, G. Almuaythir1, H. Alrasheed1, O. Alharbi2, N. Azzam2, M. Almadi2, M. Saeed2, B. HajkhderMullaissa2, A. Aljebreen2

Created: Thursday, 30 January 2020, 10:12 AM
P444: A systematic literature review (SLR) of real-world studies of advanced therapies in moderate-to-severe ulcerative colitis (UC): study, patient and clinical characteristics, and outcomes assessed
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Irving, P.M.(1);Hur, P.(2)*;Gautam, R.(3);Guo, X.(4);Vermeire, S.(5);
Created: Friday, 14 July 2023, 11:05 AM
P444: COVID-19 risk factors, infection course and vaccination among patients with inflammatory bowel disease based on a Hungarian cohort
Year: 2022
Source: ECCO'22
Authors: Farkas, K.(1);Matuz, M.(2);Kata, D.(3);Földesi, I.(3);Resál, T.(1);Bacsur, P.(1);Szántó, K.(1);Kolarovszki-Erdei, D.(1);Rutka, M.(1);Fábián, A.(1);Bor, R.(1);Szepes, Z.(1);Sarlós, P.(4);Miheller, P.(5);Zacháry, A.(6);Molnár, T.(1);
Created: Friday, 11 February 2022, 3:52 PM
P444: Does one size truly fit all? Co-prescription of allopurinol and thiopurine therapy results in variation of TGNs outside the therapeutic range in more than half of patients
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Johnston E.*1, Warner B.1, Fong S.1, Arenas-Hernandez M.2, Marinaki A.2, Anderson S.1, Sanderson J.1, Irving P.1

Created: Wednesday, 20 February 2019, 10:36 AM
P444: Fecal calprotectin response to anti-tumor necrosis factor alpha induction and maintenance in Pediatric Inflammatory Bowel Disease
Year: 2021
Source: ECCO'21 Virtual
Authors: Matar, M.(1);Levi, R.(2);Zvuloni, M.(3);Shamir, R.(1,3);Assa, A.(1,4);
Created: Wednesday, 2 June 2021, 4:12 PM
P444: Post-induction Infliximab trough levels in severe and moderate paediatric ulcerative colitis: preliminary data of a retrospective, population cohort-based study
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

M. Martinelli*1,2, H. Moore2, N. Devas2, A. Galgano2, R. N. Baldassano2

Created: Friday, 22 February 2019, 9:41 AM
P445 Efficacy and safety of induction therapy with calcineurin inhibitors followed by maintenance therapy with vedolizumab in severe ulcerative colitis: a large patient cohort with long-term follow-up
Year: 2020
Source:

ECCO'20 Vienna

Authors:

J. OLLECH1, S. Dwadasi1, I. Normatov1, A. Israel1, V. Rai1, P. Sossenheimer1, B. Christensen2, S. Dalal1, J. Pekow1, A. Sakuraba1, R. Cohen1, D. Rubin1

Created: Thursday, 30 January 2020, 10:12 AM